- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
克龄蒙反加疗法对子宫内膜异位症患者血清性激素及GnRHa所致不良反应影响
克龄蒙反加疗法对子宫内膜异位症患者血清性激素及GnRHa所致不良反应影响
摘 要 目的:探?克龄蒙反加疗法对子宫内膜异位症患者血清性激素及GnRHa所致不良反应的影响。方法:选取行腹腔镜手术治疗后的子宫内膜异位症患者100例,依据随机数表法分为对照组和反加组各50例,对照组患者于月经来潮3 d后给予3.75 mg曲普瑞林皮下注射治疗,反加组患者在此基础上给予口服克龄蒙治疗,采用酶联免疫吸附法(ELISA)检测血清雌二醇(E2)、黄体期的卵泡刺激素(FSH)、黄体生成素(LH)水平,采用视觉模拟评分法(VAS)评估疼痛程度,随访6个月,统计分析所有患者妊娠、复发和治疗前后血清FSH、E2、LH水平、治疗前、治疗后2、4、6个月的疼痛程度及治疗期间不良反应发生情况。结果:对照组和反加组患者妊娠率和复发率基本相同(P0.05);反加组患者治疗后E2、LH水平明显高于对照组(P0.05);反加组患者FSH水平、治疗后2、4、6个月的VAS得分及不良反应发生率明显低于对照组(P0.05)。结论:克龄蒙反加疗法对子宫内膜异位症无不良影响,可有效改善患者血清性激素水平和疼痛症状,减少治疗期间不良反应的发生。
关键词 克龄蒙反加疗法 子宫内膜异位症 血清性激素 不良反应
中图分类号:R711.71; R977.12 文献标识码:B 文章编号:1006-1533(2017)01-0031-03
Effect of add-back therapy with climen on the serum levels of sex hormone and the adverse reactions caused by GnRHa in patients with endometriosis*
YU Changhong**
(Department of Obstetrics and Gynecology, the People’s Hospital of Shangrao County, Shangrao 334100, China)
ABSTRACT Objective: To discuss the effect of add-back therapy with climen on the serum levels of sex hormone and the adverse reactions caused by gonadotrophin releasing hormone agonist (GnRHa) in patients with endometriosis. Methods: One hundred patients with endometriosis, who underwent laparoscopic surgery, were selected and divided into a control group and an add-back therapy group according to the random number table with 50 cases each. The control group was treated by subcutaneous injection of 3.75 mg triptorelin three days after menstrual cramps while the add-back therapy group by oral climen besides triptorelin. The levels of serum estradiol (E2), luteal phase follicle-stimulating hormone (FSH), luteinizing hormone (LH) were determined by enzyme-linked immunosorbent (ELISA), and pain intensity was assessed by visual analogue scale (VAS). All the patients were followed up for 6 months, and the indexes mentioned above at different time points and the adverse reactions occurred during the treatment were statistically analyzed. Results: The rates of pregnancy and recurrence were basically
文档评论(0)